Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR [R41]
ArchivedNational Institutes of Health
Description
Purpose. The goal of this Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) is to facilitate the development of new, more effective treatments for tobacco dependence. Mechanism of Support. This FOA will utilize the STTR (R41) grant mechanisms for Phase I applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 4-7 projects awarded as a result of this announcement is $1,500,000 for fiscal year 2011. Future year amounts will depend on annual appropriations. Budget and Project Period. For these Phase I projects, budgets up to $300,000 total costs for a time period of up to one year may be requested.
Who can apply
- Small businesses
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedAug 26, 2010
- ClosesJan 13, 2011
- Award ceiling$300,000
- Program funding$1,500,000
- CFDA93.279
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro